Robert M. Turner, II, MD
High-grade bladder Ca: New data improve risk stratification
“We need to identify those patients with high-grade T1 bladder cancer that are likely to recur or progress… and find additional options to prevent recurrence and progression in these patients,” said Joaquim Bellmunt, MD, PhD, in a presentation at the SUO annual meeting.
RCC: Multiple pathways provide therapeutic targets
Read highlights from a presentation by Toni K. Choueiri, MD, at the Society of Urologic Oncology annual meeting.
How surgical coaching helps performance, outcomes
UT SUO internship program member Robert M. Turner, II, MD, reports on a recent keynote addressing current coaching initiatives and their impact on outcomes.
How renal mass biopsy impacts management
Urology Times SUO internship program member Robert M. Turner, II, MD, reports on a recent presentation by J. Stuart Wolf, Jr., MD, about possible pitfalls of renal mass biopsy.

Poll